1Chen C H, Ferreira J C B, Gross E R, et al. Targeting aldehyde de- hydrogenase 2 : new therapeutic opportunities [J]. Physiological re- views, 2014, 94(1) : 1-34.
2Ebert A D, Kodo K, Liang P, et al. Characterization of the molecular mechanisms underlying increased isehemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluri- potent stem cell model system [ J ]. Science translational medicine, 2014, 6(255 ) : 255ra130-255ra130.
3Zhang Y, Mi S L, Hu N, et a|. Mitochondrial aldehyde dehydrogen- ase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sial, and mitochondrial function [J]. Free Radical Bioloa'v and Medicine. 2014. 71 : 208-220.
4Han H, Wang H, Yin Z, et al. Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardi- al infarction: a meta-analysis[ J. Gene, 2013,526(2) : 134-141.
5Mali V R, Ning R, Chen J, et al. Impairment of aldehyde dehydro- genase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyo- cyte hypertrophy in mice fed a high-fat diet and injected with low- dose streptozotocin[J]. Experimental Biology and Medicine, 2014: 1535370213520109.
